Neoadjuvant PD-1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung.
Feng Y, Sun W, Zhang J, Wang Y, Chen J, Liu X, Wang L, Li S, Lv C, Lu F, Zhang J, Hong Y, Xiao S, Wang T, Jiao R, Wang Z, Qi L, Li N, Yang Y, Lin D, Fang J.
Feng Y, et al. Among authors: wang l, wang z, wang y, wang t.
Thorac Cancer. 2022 Feb;13(3):442-452. doi: 10.1111/1759-7714.14280. Epub 2021 Dec 15.
Thorac Cancer. 2022.
PMID: 34913597
Free PMC article.